期刊文献+

多粘菌素B联合美罗培南用于泛耐药铜绿假单胞菌体外抗菌活性的有效性分析 被引量:10

The Effectiveness Analysis of Polymyxin B in Combination with Meropenem for Pan-drug Resistant Pseudomonas Aeruginosa Vitro Antimicrobial Activity
下载PDF
导出
摘要 目的:对多粘菌素B联合美罗培南用于泛耐药铜绿假单胞菌体外抗菌活性的有效性进行分析。方法:用微量肉汤稀释法、棋盘法等对多粘菌素B与美罗培南单独用药及两者联合用药后进行测定,临床分离出的60株泛耐药铜绿假单胞菌的最小抑菌浓度(MIC),并计算出部分抑菌浓度指数(FIC),同时依据FIC指数来判定出联合效应的类型,判定其有效性。结果:多粘菌素B和美罗培南在联用后,药物对泛耐药铜绿假单胞菌的MIC值都明显降低,FIC指数处于0-0.5的占全部菌株数量的60%;FIC指数处于0.5-1.0的占全部菌株数量的30%;FIC指数处于1.0-2.0的占全部菌株数量的10%;无FIC指数大于2的菌株。结论:多粘菌素B和美罗培南两药联用后,主要以协同作用及相加作用为主,测定分离的60株泛耐药铜绿假单胞菌具备抗菌作用,但是并不具备拮抗作用。多粘菌素B联合美罗培南用于疾病临床治疗,可有效提高临床治疗效果,且安全性较高,值得临床推广。 Objective:To analyze the effectiveness of polymyxin B in combination with meropenem for pan-drug resistant pseudomonas aeruginosa vitro antimicrobial activity.Method:After polymyxin B and meropenem were used alone and used together, the minimum inhibitory concentration of the 60 strains of pan-drug resistant pseudomonas aeruginosa which were clinically separated was tested through broth dilution method, checkerboard method and so on.And also the fractional inhibitory concentration index(FIC) was calculated.At the same time, the type and the effectiveness of the joint effect was determined according to the fractional inhibitory concentration index.Result:After the joint use of Polymyxin B and Meropenem, the fractional inhibitory concentration index of the medicine on the pan-drug resistant pseudomonas aeruginosa significantly reduced.Among these 60 strains of pan-drug resistant pseudomonas aeruginosa, those whose FIC at 0-0.5 accounted for 60%, at 0.5-1.0 accounted for 30%, at 1.0-2.0 accounted for 10%, but none of them whose FIC was over 2.Conclusion:When Polymyxin B and Meropenem are used together, they are mainly dominated by synergistic and additive effect.The 60 strains of pan-drug resistant pseudomonas aeruginosa which are separated have antibacterial effect.However, they do not have antagonistic effects.
作者 余美玲
出处 《中国医学创新》 CAS 2015年第4期112-115,共4页 Medical Innovation of China
关键词 多粘菌素B 美罗培南 泛耐药 铜绿假单胞菌 有效性 Polymyxin B Meropenem Pan-resistant Pseudomonas aeruginosa Effectiveness
  • 相关文献

参考文献15

二级参考文献116

共引文献519

同被引文献174

  • 1肖红丽,曹邦伟,荷欢,阴赪宏.美罗培南与亚胺培南治疗中、重度肺部感染疗效与安全性的荟萃分析[J].中国感染与化疗杂志,2010,10(4):264-269. 被引量:40
  • 2刘立凡,陈佰义.多粘菌素B与美罗培南联合用药对泛耐药铜绿假单胞菌体外抗菌活性的研究[J].中国生化药物杂志,2014,34(2):39-41. 被引量:11
  • 3赵宗珉,万建华,李丽云.哌拉西林/他唑巴坦治疗术后腹腔感染140例临床疗效观察[J].中华医院感染学杂志,2005,15(8):937-938. 被引量:5
  • 4中华人民共和国卫生部.涉及人的生物医学研究伦理审查办法(试行)[S].北京:中华人民共和国卫生部,2007.
  • 5Little ML, Qin X, Zerr DM, eta|. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobac- teriaceae[J]. Int J Antimicrob Agents, 2012, 39(1)~ 52- 57.
  • 6Zhang R, Cai JC, Zhou HW, et al. Genotypie characterization and in vitro activities of tigecycline and polymyxin I3 for mem- bers of the Enterobacteriaceae with decreased susceptibility to carbapenems[J]. J Med Microbiol, 2011, 60(Pt 12) : 1813 - 1819.
  • 7Miriagou V, Tzelepi E, Gianneli D, et aI. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-[3-1actamase VIM-I[J~. Antimicrob Agents Chemoth- er,2003,(1) : 395-397.
  • 8Yong D, Toleman MA, Giske CG, et aL Characterization of a new metallo-~-lactamase gene, bla ( NDM - 1 ), and a novel erythrornycin esterase gene carried on a unique genetic struc- ture in Klebsiella pneumoniae sequence type 14 from India [J]. Antimicrob Agents Chemother, 2009,53 (12) : 5046 - 5054.
  • 9Potron A,Rondinaud E,Poirel L,et al. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D 13-1actamase from Enterobaeteriaceae[-J]. Int J Antimicrob Agents,2013,41(4) .. 325-329.
  • 10Logan LK. Carbapenem-resistant Enterobacteriaceae: an emerging problem in children[J]. Clin Infect Dis, 2012, 55(6) : 852 - 859.

引证文献10

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部